Traws Pharma, Inc.
USD0.61
-0.00 (-0.67%)
CEO
Iain D. Dukes
IPO Date
2013-07-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.62
Prev. Close
$0.61
Day Low
$0.61
Day High
$0.63
52W Low
$0.60
52W High
$3.27
Market Cap
$0.01B
Volume
0.08M
| 14,150 |
| $0.68 |
| 15 Jul 2026 | Savchuk Nikolay | director, officer: Chief Operating Officer | A-Award | Acquired | 93,000 | $0.68 |
| 14 Jul 2026 | STOVER JACK E | director | A-Award | Acquired | 14,150 | $0.68 |
| 14 Jul 2026 | Dukes Iain D. | director, officer: Chief Executive Officer | A-Award | Acquired | 274,000 | $0.68 |
| 14 Jul 2026 | Redfield Robert | Chief Medical Officer | A-Award | Acquired | 84,000 | $0.68 |
| 14 Jul 2026 | Parker Charles Nolan | Chief Financial Officer | A-Award | Acquired | 90,000 | $0.68 |
| 14 Jul 2026 | Shoemaker Mary Teresa | director | A-Award | Acquired | 14,150 | $0.68 |
| 14 Jul 2026 | Clarke Trafford | director | A-Award | Acquired | 14,150 | $0.68 |
| 14 Jul 2026 | Leaman John Harold | director | A-Award | Acquired | 14,150 | $0.68 |